ConductScience.org, home

Paper42440201

Sexual Dysfunction Among Males Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross-sectional Study.

Kiguba R and 3 others. Drug Saf, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Sexual Dysfunction Among Males Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross-sectional Study. Papers, record 42440201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42440201

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sexual Dysfunction Among Males Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross-sectional Study.
PubMed
Journal
Drug Saf
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-10-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kiguba RRonaldhttps://orcid.org/0000-0002-2636-4115
2Ssesanga MMishael
3Odongpiny EALEva Agnes Laker
4Pirmohamed MMunir

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Heterocyclic Compounds, 3-RingMajor topic
HIV InfectionsMajor topic
Erectile DysfunctionMajor topic
Anti-HIV AgentsMajor topic
Humans
Male
Piperazines
Dolutegravir
Cross-Sectional Studies
Oxazines
Pyridones
Adult
Uganda
Middle Aged
Prevalence

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MR/V030434/1Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References28

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127984559Psychiatric Symptoms in Patients Receiving Dolutegravir.J Acquir Immune Defic Syndr2017https://conductscience.org/library/papers/27984559PubMed
217263654Erectile dysfunction and hypogonadism among men with HIV.AIDS Patient Care STDS2007https://conductscience.org/library/papers/17263654PubMed
317851990Sexual dysfunction in HIV-positive men is multi-factorial: a study of prevalence and associated factors.AIDS Care2007https://conductscience.org/library/papers/17851990PubMed
429746295The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?AIDS2018https://conductscience.org/library/papers/29746295PubMed
519473282Selective serotonin reuptake inhibitor-induced sexual dysfunction.J Sex Med2009https://conductscience.org/library/papers/19473282PubMed
612650685What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?Psychoneuroendocrinology2003https://conductscience.org/library/papers/12650685PubMed
733807833HIV and Sexual Dysfunction in Men.J Clin Med2021https://conductscience.org/library/papers/33807833PubMed
815034836Risk of metabolic abnormalities in patients infected with HIV receiving antiretroviral therapy that contains lopinavir-ritonavir.Clin Infect Dis2004https://conductscience.org/library/papers/15034836PubMed
9447779Bias in analytic research.J Chronic Dis1979https://conductscience.org/library/papers/447779PubMed
109493486The Changes in Sexual Functioning Questionnaire (CSFQ): development, reliability, and validity.Psychopharmacol Bull1997https://conductscience.org/library/papers/9493486PubMed
1127860104Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients.HIV Med2017https://conductscience.org/library/papers/27860104PubMed
1239698577Erectile dysfunction in men with human immunodeficiency virus: prevalence and associated factors.Transl Androl Urol2024https://conductscience.org/library/papers/39698577PubMed
1339853832A programmatic assessment of dolutegravir adverse events and discontinuations in Uganda.HIV Med2025https://conductscience.org/library/papers/39853832PubMed
149858756What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?Brain Res Brain Res Rev1998https://conductscience.org/library/papers/9858756PubMed
1535971109Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study.BMC Infect Dis2022https://conductscience.org/library/papers/35971109PubMed
1621880989Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction.Pharmacol Rev2011https://conductscience.org/library/papers/21880989PubMed
1736261884The impact of dolutegravir-based combination antiretroviral therapy on the spermatozoa and fertility parameters of men living with human immunodeficiency virus.Andrologia2022https://conductscience.org/library/papers/36261884PubMed
1819915446Risk factors for sexual and erectile dysfunction in HIV-infected men: the role of protease inhibitors.AIDS2010https://conductscience.org/library/papers/19915446PubMed
1940975083Adverse drug reaction reporting with the Med Safety app in Uganda: a cluster-randomised, controlled trial.Lancet Glob Health2025https://conductscience.org/library/papers/40975083PubMed
2041203969Sexual Dysfunction in Male Patients After Initiating Treatment with Antidepressants.Drug Saf2026https://conductscience.org/library/papers/41203969PubMed

See all 28 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42440201

GET https://conductscience.org/api/papers/v1/42440201/references?page=2